These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24033615)

  • 1. An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment.
    Peterson L; Marbury T; Marier J; Laliberte K
    J Clin Pharm Ther; 2013 Dec; 38(6):518-23. PubMed ID: 24033615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers.
    Jones A; Wang-Smith L; Pham T; Laliberte K
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):227-32. PubMed ID: 24603117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
    Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
    J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of treprostinil diolamine in subjects with end-stage renal disease on or off dialysis.
    Jenkins A; Wang-Smith L; Marbury T; Laliberte K
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):272-6. PubMed ID: 23188123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension.
    White RJ; Torres F; Allen R; Jerjes C; Pulido T; Yehle D; Howell M; Laliberte K; Marier JF; Tapson VF
    J Cardiovasc Pharmacol; 2013 Jun; 61(6):474-81. PubMed ID: 23328389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of a pharmacokinetic interaction between treprostinil diolamine and sildenafil in healthy adult volunteers.
    Gotzkowsky SK; Kumar P; Mottola D; Laliberte K
    J Cardiovasc Pharmacol; 2013 May; 61(5):444-51. PubMed ID: 23429588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers.
    Gotzkowsky SK; Dingemanse J; Lai A; Mottola D; Laliberte K
    J Clin Pharmacol; 2010 Jul; 50(7):829-34. PubMed ID: 20133511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers.
    Zhao Q; Iyer GR; Verhaeghe T; Truyen L
    J Clin Pharmacol; 2002 Apr; 42(4):428-36. PubMed ID: 11936568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
    Jing ZC; Parikh K; Pulido T; Jerjes-Sanchez C; White RJ; Allen R; Torbicki A; Xu KF; Yehle D; Laliberte K; Arneson C; Rubin LJ
    Circulation; 2013 Feb; 127(5):624-33. PubMed ID: 23307827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration.
    Kumar P; Thudium E; Laliberte K; Zaccardelli D; Nelsen A
    Clin Pharmacokinet; 2016 Dec; 55(12):1495-1505. PubMed ID: 27286723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.
    Coons JC; Miller T
    Ther Adv Respir Dis; 2018; 12():1753466618766490. PubMed ID: 29609511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
    LeVarge BL; Channick RN
    Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension.
    Channick RN; Olschewski H; Seeger W; Staub T; Voswinckel R; Rubin LJ
    J Am Coll Cardiol; 2006 Oct; 48(7):1433-7. PubMed ID: 17010807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treprostinil for the treatment of pulmonary arterial hypertension.
    Torres F; Rubin LJ
    Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension.
    Hellawell JL; Bhattacharya S; Farber HW
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1445-53. PubMed ID: 25204984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treprostinil for the treatment of pulmonary arterial hypertension.
    de Lartigue J
    Drugs Today (Barc); 2014 Aug; 50(8):557-65. PubMed ID: 25187906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion.
    Wade M; Baker FJ; Roscigno R; DellaMaestra W; Hunt TL; Lai AA
    J Clin Pharmacol; 2004 Jan; 44(1):83-8. PubMed ID: 14681345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
    Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
    J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic modelling of treprostinil after intravenous injection and extended-release oral tablet administration in healthy volunteers: An extrapolation to other patient populations including patients with hepatic impairment.
    Wu X; Zhang X; Xu R; Shaik IH; Venkataramanan R
    Br J Clin Pharmacol; 2022 Feb; 88(2):587-599. PubMed ID: 34190364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.